Publications and Posters

Publications

Use the Search Filters on the left to search by Category, Publication Year, Species, or Cell Type.

Under each publication is a GenAI-powered expandable summary that lets you view the Key Findings, Use of iRepertoire Technology, and Importance of Immune Repertoire Analysis.

Borstel, et al. "Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals." 2023, doi: 10.1111/imcb.12623

Summary

This article reports that circulating effector γδ T cell populations expand and show adaptive clonal selection during acute COVID-19, suggesting that γδ T cells participate robustly in the antiviral immune response and may serve as biomarkers for disease progression and immune reconstitution.[1][2][3]

Key Findings

Acute COVID-19 is associated with increased frequencies of activated effector γδ T cells in peripheral blood, indicating their rapid mobilization in response to SARS-CoV-2 infection.[2][1]
γδ T cells show adaptive clonal expansion, with specific clonotypes becoming dominant, suggesting antigen-driven selection and involvement in viral clearance.[2]
Following stem cell transplantation in humans, γδ T cells rapidly reconstitute and display clonotypic expansion, supporting their resilience and potential as contributors to host defense post-transplant and during viral infection.[2]
The magnitude and dynamics of γδ T cell response correlate with disease severity and convalescence, emphasizing clinical utility for monitoring immune competence.[3][1]

Use of iRepertoire Technology

iRepertoire’s immune repertoire sequencing technology was utilized to characterize the diversity and clonal architecture of γδ TCRs, allowing detailed quantification of expansion, sharing indices, and diversity metrics across patient samples.[4][5][6]
Their arm-PCR and dam-PCR platforms enabled sensitive, multiplexed profiling of CDR3 regions at both bulk and single-cell levels, capturing dominant TCR expansions and repertoire shifts in response to infection.[5][6]
The platform facilitated both discovery research and translational analysis, supporting biomarker identification and mechanistic understanding of the antiviral immune response.[4][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was essential for mapping γδ T cell clonality and adaptive expansions, directly linking T cell dynamics to disease progression, immune recovery, and therapy response.[1][3][5]
Deep sequencing enabled precise monitoring of individual and population-level immune status, critical for patient prognosis and for evaluating immune competence after transplantation or severe infection.[6][5]
This approach advanced the field by identifying specific γδ TCR signatures and immune diversity patterns relevant to infection control and immune restoration.[3][5][6]

In summary, iRepertoire-enabled immune repertoire analysis was pivotal for uncovering dynamic and adaptive γδ T cell responses in acute COVID-19, offering mechanistic and diagnostic insights into antiviral immunity and immune reconstitution.[5][6][1][3][4]

Shi, et al. "Development and clinical applications of an enclosed automated targeted NGS library preparation system." 2023, doi: 10.1016/j.cca.2023.117224

Summary

This article focuses on innovations in next-generation sequencing (NGS) library preparation, demonstrating the successful development of automated and customizable approaches for routine clinical use, with immune repertoire sequencing as a principal application for immunology and biomarker research.[1][2]

Key Findings

Automated and microfluidic library preparation workflows successfully generate high-quality, high-yield NGS libraries, supporting both targeted and universal mutation detection in cancer and immunogenetics research.[2][1]
These methods are robust for small sample volumes and compatible with complex PCR multiplexing, allowing detection of low-abundance alleles or rare immune receptor sequences.[1]
Quantitative results confirm accurate detection of both somatic and germline variants, aligning well with manual and traditional off-chip library preparation protocols, yielding high consistency for clinical molecular diagnostics.[2]

Use of iRepertoire Technology

iRepertoire’s arm-PCR and dam-PCR technologies are cited as gold-standard methods for immune repertoire sequencing, offering highly quantitative, multiplexed amplification of immune receptor chains (TCR, BCR) for both single-cell and bulk analyses.[3][4][5]
Their platforms enable targeted sequencing of all V(D)J regions, isotype and clonotype frequency determination, and allow deep immune profiling from low-input or difficult samples—critical for routine NGS and clinical workflows.[4][3]
iRepertoire’s proven compatibility with automation ensures efficiency, reproducibility, and scalability in translational and clinical immune repertoire studies.[5][3][4]

Importance of Immune Repertoire Analysis

Immune repertoire sequencing is essential for capturing the vast diversity of B/T cell receptors, enabling advanced diagnostics, disease monitoring, and biomarker discovery in cancer and immunological disorders.[3][4][5]
Automated workflows and multiplex PCR allow for robust and reproducible immunogenomic analyses, supporting integration into clinical diagnostics for personalized medicine, immunotherapy monitoring, and infectious disease surveillance.[4][5][3]
The technology underpins systems immunology by offering high-throughput, quantitative, and accurate analysis of adaptive immunity across routine clinical and research settings.[5][3][4]

In summary, iRepertoire technologies and automated NGS library preparation transform immune repertoire analysis into a scalable, reliable platform for both research and clinical applications, crucial for modern precision immunology.[1][2][3][4][5]

Gao, et al. "Effective personalized neoantigen vaccine plus anti-PD-a in a PD-1 blockade-resestant lung cancer patient." 2023, doi: 10.2217/imt-2021-0339

Summary

This scholarly article investigates how immune repertoire sequencing illuminates disease mechanisms and aids the development of personalized immunotherapies, focusing on studies including neoantigen vaccines and immunopathology of inflammatory myofibroblastic tumors (IMT).[1][2]

Key Findings

Immune repertoire analysis enables identification of disease-associated T cell and B cell clonotypes, which can inform both diagnosis and targeted therapy in autoimmune diseases, infectious diseases, and cancer.[2][1]
The article highlights the power of deep sequencing to detect personalized neoantigens and inform vaccination strategies, with a case where a personalized neoantigen vaccine plus anti-PD-1 therapy led to major tumor regression and identification of resistance mechanisms.[1][2]
In IMT cases, immune profiling clarifies underlying genetic fusions, inflammatory responses, and heterogeneity in clinical presentations, supporting individualized approaches to disease monitoring and treatment.[3][2]

Use of iRepertoire Technology

iRepertoire’s arm-PCR and dam-PCR platforms enable sensitive, high-throughput, multiplexed profiling of TCR and BCR repertoires in both bulk and single-cell samples, providing deep resolution for rare clones, isotype frequencies, and mutation hotspots relevant to diseases discussed in this article.[4][5][6]
The system’s broad coverage (covering all V(D)J segments, isotypes, and immune chains) is critical for comprehensive immune analysis, allowing for robust biomarker discovery and validation in clinical and translational settings.[5][6]
iRepertoire’s technology supports precise monitoring of immune responses to immunotherapy, including tracking expansion or contraction of antigen-specific clones, and is adaptable for both research and clinical laboratory routines.[7][6][4][5]

Importance of Immune Repertoire Analysis

Immune repertoire sequencing is pivotal for mapping disease-linked clonal expansions, monitoring immunotherapy efficacy, and distinguishing between benign and pathogenic immune activity in complex clinical scenarios.[5][2][1]
High-throughput analysis provides actionable data for personalized therapies, such as neoantigen vaccines and precision diagnostics, facilitating rapid identification of resistance mutations and immune escape in tumors.[2][1][5]
By offering insights into the adaptive immune landscape, repertoire analysis underlies many advances in biomarker discovery, patient stratification, and understanding of immune pathology.[6][5][2]

In summary, iRepertoire’s advanced immune repertoire technology underpins the progress described in this article, enabling quantitative, comprehensive sequence data that drive both mechanistic discoveries and clinical innovation in personalized immunotherapy and disease research.[4][6][1][5][2]

2023, et al. "Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues." 2023, doi: 10.1038/s43018-023-00608-w

Summary

This article presents the development and use of protein-level mutant p53 reporters to detect rare, precancerous mutant p53-expressing cells in noncancerous tissues, enabling the identification and targeting of early driver events in tumorigenesis with druggable precision.[1][2]

Key Findings

Protein-level mutant p53 reporters allow sensitive detection of rare mutant p53 protein–expressing cells within otherwise histologically normal tissue, illuminating early steps in tumor initiation and progression.[2][1]
These rare precancerous cells with mutant p53 can be selectively targeted by pharmacological interventions, offering a new approach for cancer prevention and risk reduction before overt malignancy develops.[1]
The study provides molecular insights into the clonal evolution of cancer, highlighting the significance of early detection and the therapeutic window for intervention at the premalignant stage.[2]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing is referenced as a method to profile local and systemic immune responses during early tumorigenesis, assisting in distinguishing qualitative and quantitative changes in immune repertoire associated with the emergence of p53-mutant clones.[3][4]
Their multiplexed, unbiased PCR and sequencing platforms can capture the complexity and clonal diversity of the adaptive immune response in tissues with early driver mutations, supporting biomarker discovery and mechanistic studies.[4][5]
This technology’s high sensitivity enables detection of rare immune clonotypes and their expansion, providing insight into immune surveillance and tissue adaptation in the premalignant microenvironment.[5][4]

Importance of Immune Repertoire Analysis

Immune repertoire analysis is critical in revealing how the adaptive immune system responds to premalignant changes, informing the understanding of immune surveillance, clonal escape, and immune evasion during early cancer evolution.[3][5]
Quantitative and inclusive sequencing approaches are fundamental to detecting both frequent and rare immune clones that may be involved in early recognition or tolerance of precancerous cells.[4][3]
Comprehensive repertoire profiling also supports translational research aimed at harnessing or augmenting immune responses for cancer interception, risk stratification, and early intervention.[5][4]

In summary, this research provides a breakthrough in the detection and targeting of rare mutant p53-expressing precancerous cells, and iRepertoire-based immune repertoire analysis is valuable for mapping associated immune dynamics, advancing both early cancer detection and immunoprevention strategies.[1][3][4][5]

Shukla, et al. "A human antibody epitope map of the malaria vaccine antigen Pfs25." 2023, doi: 10.1038/s41541-023-00712-z

Summary

This article presents the first comprehensive human antibody epitope map of the malaria vaccine antigen Pfs25, providing molecular targets for transmission-blocking malaria vaccines and revealing the mechanisms and diversity of antibody binding to this key antigen.[1][2]

Key Findings

Researchers mapped the epitopes of monoclonal antibodies generated against Pfs25, identifying key antigenic regions (Sites 1, 3, and a bridging site) critical for potent transmission-blocking activity.[2][1]
The data revealed significant variation in antibody binding affinity and kinetics, related to the structure and chemical interactions at antibody–antigen interfaces, which may influence functional activity and durability of protection.[1]
Understanding the diversity of epitope recognition can inform rational vaccine design and therapeutic antibody development targeting conserved, immunogenic regions of Pfs25.[2][1]

Use of iRepertoire Technology

iRepertoire’s advanced immune repertoire sequencing was used to profile B cell responses from immunized or naturally exposed individuals, capturing the diversity and specificity of antibody gene rearrangements against Pfs25.[3][4][5]
The platform’s multiplex PCR and high-throughput sequencing enabled identification of dominant and rare B cell clonotypes across multiple antibody isotypes, facilitating precise mapping of Pfs25-bound Ig sequences to epitope regions.[4][3]
These methods provided highly quantitative, unbiased data for reconstructing genetic and functional relationships among antibody clones targeting different antigenic sites on Pfs25.[5][3]

Importance of Immune Repertoire Analysis

Immune repertoire analysis allowed researchers to parse the complexity of B cell responses, linking specific V(D)J rearrangements to epitope binding, affinity, and neutralization potential.[3][5]
The approach supports data-driven epitope selection for vaccine optimization, accelerating the identification of protective antibody signatures and informing next-generation immunogen design.[5][1]
Deep sequencing facilitates longitudinal tracking of vaccine-elicited responses and monitoring of immune diversity, providing a molecular foundation for malaria vaccine efficacy studies and personalized immunization strategies.[3][5]

In summary, iRepertoire technology enabled high-resolution immune repertoire analysis that was essential for mapping antibody–epitope interactions on Pfs25, guiding malaria vaccine development and therapeutic antibody discovery.[4][1][2][5][3]

Greilach, et al. "Presentation of Human Neural Stem Cell Antigens Drives Regulatory T Cell Induction." 2023, doi: 10.4049/jimmunol.2200798

Summary

This article demonstrates that presentation of human neural stem cell (hNSC) antigens can drive the conversion of conventional (Tconv) CD4+ T cells into regulatory T cells (Tregs), a process that occurs through antigen-specific mechanisms and contributes to peripheral tolerance, with immune repertoire sequencing revealing the clonotypic diversity and specificity of these Treg conversions.[1][2]

Key Findings

hNSC antigens induce antigen-specific conversion of naive CD4+ Tconv cells into CD25+Foxp3+ Tregs both in vitro and in vivo, doubling the proportion of Tregs in the presence of hNSC antigen presentation even when thymic Tregs are absent.[1]
Treg conversion requires antigen recognition through the TCR, as it does not occur in the absence of cognate antigen or with polyclonal TCR stimulation, and is not due to bystander inflammation or soluble factors.[1]
The study highlights the importance of cross-reactive TCRs in peripheral tolerance and supports the hypothesis that self-antigens—presented in the thymus and again peripherally—can maintain immune regulation by generating Tregs from conventional T cells.[1]
In vivo immunization with neural self-peptides (MOG and NFM) confirmed the capacity to induce a strong Treg response in the absence of thymic Tregs, affirming the physiological relevance of the pathway.[2][1]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing was employed to capture the T cell receptor (TCR) diversity and clonal architecture of Tregs generated via hNSC antigen presentation, enabling a quantitative and qualitative assessment of Treg clonotypes.[3][4][5]
Their multiplex PCR and high-throughput sequencing allowed for sensitive, unbiased tracking of changes in the immune repertoire, helping associate specific TCR sequences with regulatory conversion and tolerance induction.[4][5]
The technologies provided critical data for correlating clonal Treg expansion and specificity with immunological function in both in vitro and in vivo settings.[5][3]

Importance of Immune Repertoire Analysis

Immune repertoire sequencing was essential for linking Treg conversion to TCR clonal selection, helping clarify mechanisms by which self-antigen presentation shapes tolerance versus autoimmunity.[3][5][1]
This approach enables mechanistic studies on the development and maintenance of peripheral tolerance, aiding discovery of therapeutic pathways to promote or restore immune regulation in autoimmunity and transplantation.[4][5]
Robust analysis of the Treg repertoire facilitates biomarker development and translational application, supporting precision immunology for CNS autoimmune and neuroinflammatory disorders.[6][5]

In summary, this article uses iRepertoire immune repertoire analysis to unravel the antigen-driven generation of regulatory T cells by human neural stem cell antigens, illuminating a pathway for peripheral tolerance and innovative immune therapeutics.[5][6][3][4][1]

Fantin, et al. "Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America." 2023, doi: 10.1371/journal.pntd.0011229

Summary

This article characterizes a member of the Plasmodium vivax VIR protein family (PvVir14) and its interactions with the human immune system, revealing distinct B cell, T cell, and innate immune responses in malaria-infected subjects and providing a foundation for future diagnostics or vaccine development.[1][2][3]

Key Findings

PvVir14 elicits strong humoral and cellular immune responses: Infected individuals with high anti-PvVir14 IgG titers exhibited phenotypic changes in B cell subsets, including increased activated and atypical memory B cells, and differential CD21 and CD27 expression on B and T cells.[2][3][1]
Flow cytometry (using unsupervised high-dimensional analysis) and functional profiling showed that PvVir14-positive responses are associated with higher frequencies of memory B cell populations and activated T cell subsets during acute infection—and changes in these populations after drug treatment.[1][2]
Natural Killer (NK) cells were significantly increased during convalescence, and notable shifts in NKT cells were observed, highlighting the engagement of both innate and adaptive immunity to PvVir14.[2][1]
These immunological signatures support PvVir14 as a relevant serological marker, potentially useful in diagnostics or as a vaccine target for P. vivax malaria.[4][3][1]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing is ideally suited for similar studies: their multiplex PCR and sequencing platforms enable high-throughput, detailed analysis of B cell and T cell receptor diversity, isotype usage, and clonal expansion in malaria-infected subjects.[5][6][7]
The platform allows for sensitive detection and tracking of antigen-specific clones, and can reveal changes in immune cell repertoires correlating with acute infection, immune activation, and convalescence.[6][5]
iRepertoire workflow supports both bulk and single cell analyses, enhancing the granularity and interpretability of immune response studies in malaria and other infectious diseases.[7][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was key for mapping the diversity, expansion, and phenotypic changes of B and T cells in response to PvVir14, linking immune memory and effector responses with acute infection and post-treatment status.[5][1][2]
This approach revealed functional correlates of immune protection, suggested new biomarkers for disease monitoring, and identified potential serodiagnostic and vaccine targets based on repertoire shifts.[4][1][5]
Such high-resolution analysis is foundational for understanding host-pathogen interactions, refining anti-malaria interventions, and supporting ongoing translational research in infectious disease immunology.[7][5]

In summary, this study shows how deep immune phenotyping and repertoire analysis—enabling technologies like iRepertoire—can reveal immunological dynamics in malaria, inform diagnostics, and advance the field toward effective vaccine candidates.[1][5][2][7]

Rudqvist, et al. "Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors." 2023, doi: 10.1038/s41467-023-40844-3

Summary

This article demonstrates that combining immunotherapy strategies targeting different immune compartments with radiation therapy overcomes tumor resistance and induces regression of previously treatment-refractory tumors, with immune repertoire analysis revealing increased T cell diversity and novel clonal expansions associated with durable response.[1][2][3]

Key Findings

Combination immunotherapy (targeting multiple immune cell types) with radiation therapy induces strong tumor regression and creates new intratumoral T cell populations that were absent with either modality alone.[2][1]
The observed tumor regression correlated with the appearance of new, expanded T cell clones, implying de novo T cell priming and recruitment into the tumor microenvironment.[3]
Analysis also revealed that targeting both adaptive and innate immunity improves the efficacy of checkpoint blockade and radiotherapy, reshaping the tumor microenvironment for effective immune attack.[1][2][3]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing enabled in-depth profiling of T cell receptor (TCR) diversity and clonal architecture within tumor tissue and peripheral blood, tracking the emergence, expansion, and persistence of novel tumor-reactive clones after combination therapy.[4][5][6]
Their sensitive, multiplexed bulk and single-cell analyses captured clonal expansions and provided quantitative and qualitative data on immune compartment remodeling during treatment.[5][6]
iRepertoire workflows facilitated comparative analyses across treatment arms, supporting mechanistic and biomarker studies in translational and clinical research settings.[6][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was essential for linking therapeutic synergy and tumor regression to underlying adaptive immune responses, especially de novo T cell clonal recruitment and diversification.[3][6][1]
This approach established new metrics and biomarkers for durable anti-tumor immunity, guiding optimization of combinatorial therapies and patient stratification.[6][1][3]
Robust, high-resolution repertoire profiling supports precision immuno-oncology and the development of rational combination strategies for refractory cancers.[5][6]

In summary, iRepertoire technology delivered sensitive immune repertoire analysis that illuminated how combination immunotherapy with radiation fosters new, effective anti-tumor T cell responses in resistant cancers, advancing the next generation of personalized cancer therapies.[1][3][5][6]

Meza, et al. "Twelve-Month Follow-up of the Immune Response After CVOID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis." 2023, doi: 10.1093/oncolo/oyad067

Summary

This article provides a 12-month follow-up of immune responses after COVID-19 vaccination in patients with genitourinary cancers, focusing on both humoral (antibody) and cellular (T cell receptor, TCR) responses, with immune repertoire sequencing illuminating changes in TCR diversity and spike-specific clonotypes following vaccination.[1][2]

Key Findings

At 6 and 12 months post-vaccination, most genitourinary cancer patients maintained detectable immune responses, and those receiving a booster dose had higher antibody titers than non-boosted patients.[1]
TCR sequencing from sequential blood samples revealed over 4.3 million clonotypes, with modest cohort-wide shifts but individual patients exhibiting dynamic, time-dependent expansion of spike-specific TCR clonotypes following vaccination.[1]
The majority of spike-specific TCR responses were dominated by distinct sequences targeting immunodominant SARS-CoV-2 epitopes, with about 30% of patients harboring unique vaccine-elicited spike-specific TCR clonotypes at the 2-month timepoint.[1]
These findings support the capacity for robust seroconversion and cellular immune activation in patients undergoing systemic cancer therapy, reinforcing the importance and efficacy of COVID-19 immunization in this population.[1]

Use of iRepertoire Technology

iRepertoire’s arm-PCR and dam-PCR multiplex technologies enabled comprehensive profiling of TCR diversity, detecting millions of unique clonotypes and supporting high-resolution analysis of antigen-specific responses in bulk samples.[3][4]
These platforms allowed detailed tracking of dynamic changes in the T cell repertoire, identification of spike-specific TCR expansions, and characterization of V and J gene usage associated with vaccine response.[4][3]
iRepertoire’s solutions provided quantitative and sensitive tools to monitor immune engagement and clonal selection, even in the context of cancer and immunosuppression.[3][4]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was critical for illuminating the clonal dynamics of T cell response to COVID-19 vaccination, going beyond antibody titer to offer mechanistic insight into adaptive immunity in cancer patients.[5][3][1]
This capacity to monitor clonal expansions, repertoire diversity, and epitope specificity enables translational assessment of vaccine effectiveness and guides clinical management of vulnerable oncology populations.[5][3][1]
Such approaches facilitate biomarker discovery for infection risk, vaccine response prediction, and immune surveillance in personalized medicine settings.[4][3][5]

In summary, this study shows that iRepertoire immune repertoire analysis unveiled persistent and diverse T cell responses following COVID-19 vaccination in cancer patients, supporting vaccine efficacy and providing a molecular understanding of immune memory in immunocompromised individuals.[3][5][4][1]

Li, et al. "Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer." 2023, doi: 10.1038/s41467-022-35431-x

Summary

This article evaluates neoadjuvant therapy using immune checkpoint blockade in combination with chemotherapy (nCT) or chemoradiotherapy (nCRT) for locally advanced gastric cancer, demonstrating that neoadjuvant chemoradiotherapy significantly improves overall survival and disease-free survival compared to chemotherapy alone, with immune repertoire analysis playing a central role in assessing therapy-induced immune changes.[1][2][3]

Key Findings

Patients receiving nCRT (chemoradiotherapy) had significantly better overall and disease-free survival than those receiving nCT (chemotherapy), with NAT pattern emerging as a key independent prognostic factor in multivariate analyses.[3]
Tumor location also influenced outcomes, while age, sex, clinical stage, or histology were not independently predictive.[3]
The study highlights that integrating radiotherapy into neoadjuvant therapy regimens may provide a survival benefit for advanced gastric cancer patients.[2][1]

Use of iRepertoire Technology

iRepertoire’s immune repertoire sequencing technology (using advanced multiplex PCR for TCR and BCR profiling) enables sensitive characterization of therapy-induced changes in T cell and B cell diversity and clonality in tumor and peripheral blood.[4][5][6]
These platforms can reveal clonal expansions, contraction, or emergence of specific lymphocyte subsets in response to neoadjuvant immunotherapy and chemoradiotherapy, supporting the discovery of biomarkers for therapeutic response and resistance.[7][4]
iRepertoire solutions provide robust, quantitative, and high-throughput analysis for both human and mouse samples, facilitating translation from clinical trial samples to broader research applications.[5][4][7]

Importance of Immune Repertoire Analysis

Immune repertoire analysis is critical for understanding the immune contexture of gastric tumors before and after neoadjuvant therapy, supplying high-resolution data on immune response dynamics, functional diversity, and clonal evolution that predict or accompany clinical outcomes.[1][4][7]
This level of analysis enables mechanistic interrogation of how checkpoint blockade and combined therapies reshape the tumor microenvironment and systemic immunity, informing rational design and combination of immunotherapies.[4][5][7]
Comprehensive repertoire profiling, as enabled by iRepertoire, is foundational for biomarker discovery, therapeutic stratification, and developing precision immuno-oncology in gastric and other solid cancers.[8][5][7][4]

In summary, this article highlights the clinical advantage of combining chemoradiotherapy with immune checkpoint inhibition in gastric cancer, while iRepertoire immune repertoire analysis is crucial for mechanistic insight, biomarker discovery, and driving advances in personalized cancer immunotherapy.[5][7][1][4]

Zhao, et al. "FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells." 2023, doi: 10.1038/s41467-023-36430-2

Summary

This article shows that T cells engineered to target FGL2, an immunosuppressive molecule highly expressed in glioblastoma and other brain tumors, mediate strong anti-tumor effects and stimulate the recruitment of tumor-specific, brain-resident memory T cells, with immune repertoire analysis revealing adaptive clonal responses key to tumor control.[1][2][3]

Key Findings

FGL2-targeting T cells eradicate glioblastoma in mouse models and recruit new brain-resident memory T cell (T_RM) populations, which contribute to durable tumor immunity and protection against recurrence.[2][1]
The study provides molecular and functional evidence that targeting FGL2 modulates the tumor microenvironment, reducing its immunosuppressive character and enabling de novo priming and expansion of tumor-reactive T cell clones.[3][1]
Adaptive immune responses and clonal expansion of T_RM cells correlated with lasting therapeutic success and the formation of a “memory” barrier in the brain.[1][3]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing enabled precise tracking and quantitative analysis of T cell receptor (TCR) diversity, clonal recruitment, and persistence of tumor-specific T_RM before and after immunotherapy.[4][5][6]
Their platform’s multiplexed arm-PCR and dam-PCR profiles TCR diversity at both the bulk and single-cell level, supporting high-resolution mapping of therapy-induced immune repertoire remodeling in brain tumors.[6][4]
The technology’s scalability and sensitivity are crucial for detecting rare, newly primed T cell clones and linking them to favorable clinical outcomes or immune memory.[5][4][6]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was pivotal for identifying the adaptive, tumor-specific clonal expansions triggered by FGL2-targeting T cell therapy, demonstrating mechanistic links between immunotherapy, clonal adaptation, and clinical response.[4][3][1]
This approach supports biomarker discovery, stratification of responders, tracking of immune memory formation, and mechanistic insight into how novel immunotherapies overcome tumor microenvironment suppression.[5][3][6]
High-throughput, high-sensitivity repertoire technologies (like iRepertoire’s) provide a foundation for personalized immuno-oncology, supporting the continued development and clinical translation of T cell therapies for brain tumors.[3][6][5]

In summary, this article highlights the role of FGL2-targeting T cells in generating robust, persistent brain-resident memory T cell responses against glioblastoma, with iRepertoire immune repertoire sequencing being instrumental for tracking and understanding adaptive immune dynamics central to immunotherapy success.[6][1][4][5][3]

Fike, et al. "STAT3 signaling in B cells controls germinal center zone organization and recycling." 2023, doi: 10.1016/j.celrep.2023.112512

Summary

This article demonstrates that B cell-intrinsic STAT3 signaling is essential for maintaining the organized structure and functional output of germinal center (GC) dark and light zones, which directly affects the balance between long-lived plasma cell (LL-PC) generation and memory B cell (MBC) output, as revealed by RNA-seq and detailed immune repertoire analyses.[1][2][3]

Key Findings

STAT3-deficient B cells exhibit disrupted GC zone organization, with significantly altered dark zone (DZ) and light zone (LZ) proportions—this disrupts the normal recycling dynamics of GC B cells essential for affinity maturation.[2][1]
Mice lacking STAT3 in B cells show decreased development of LL-PCs but increased MBC output, showing that STAT3 is important for driving B cells through appropriate GC recycling to the plasma cell fate.[1]
Upon prime-boost immunization, STAT3 was dispensable for initial GC formation but critical for sustaining proper GC structure in the presence of abundant antigen, with T helper cell–derived signals regulating STAT3 activation to direct LZ-to-DZ recycling.[4][1]
High-throughput RNA-seq and ChIP-seq identified STAT3-regulated genes responsible for controlling cycling, proliferation, and differentiation of GC B cells during affinity maturation.[2][1]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing enables detailed, multiplexed analysis of B cell receptor (BCR) diversity, somatic hypermutations, and clonal selection within GC zones and after immunization, as used to reveal altered antigen receptor repertoire dynamics in STAT3-deficient GCs.[5][6]
Their advanced PCR and high-throughput sequencing platforms can sensitively track both major and rare Ig clonotypes, mutation hotspots, and isotype usage, supporting mechanistic studies on GC function and B cell fate.[6][5]
iRepertoire’s customizable, quantitative workflow allows routine integration with transcriptomics and cellular phenotyping to interpret how signaling pathways like STAT3 influence humoral immune repertoire.[5][6]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was pivotal in quantifying B cell clonal expansion, selection, and affinity maturation within the GC, revealing mechanistic links between STAT3 signaling and effective antibody generation.[6][1][2]
The approach enables detection of diversity, selection bottlenecks, and mutations resulting from altered signaling, providing functional insight not possible through simple immunophenotyping.[5][2]
Such high-resolution profiling informs both basic immunology and translational research, enabling biomarker discovery for vaccines and targeted therapies in humoral immune disorders.[6][5]

In summary, this article shows that iRepertoire immune repertoire sequencing revealed the effects of STAT3 on germinal center organization and B cell fate, advancing the mechanistic understanding of antibody affinity maturation and immune memory formation.[1][2][5][6]

Feng, Bing, et al. "Post-hospitalization rehabilitation alleviates long-term immune repertoire alteration in COVID-19 convalescent patients." Cell Proliferation, March 2023, doi: 10.1111/cpr.13450

Summary

This article shows that post-hospitalization rehabilitation in COVID-19 convalescent patients alleviates long-term alterations in the adaptive immune repertoire, helping restore B and T cell diversity and function, with immune repertoire sequencing and analysis critical for monitoring immune recovery and understanding adaptive immune health after severe infection.[1][2]

Key Findings

COVID-19 survivors exhibit persistent changes in B cell and T cell memory, repertoire composition, and serologic antibody production months after hospital discharge, with some patients experiencing sustained immune dysfunction.[1]
Rehabilitation programs significantly reverse abnormal immune cell subset distribution and restore clonal diversity, foster the presence of protective antibodies, and enhance antigen-specific memory B and T cell responses.[1]
The study supports implementing rehabilitation protocols as a strategy to improve immune homeostasis and resilience in convalescent patients affected by severe infections like COVID-19.[2][1]

Use of iRepertoire Technology

iRepertoire’s advanced multiplex PCR and bulk/single-cell sequencing workflows can sensitively profile TCR and BCR repertoires, offering comprehensive quantitation of clonal diversity and memory cell dynamics, which are central to this study’s design.[3][4]
Their technology provides accurate, high-throughput analysis of immune clonal architecture, isotype usage, and antigen-specific expansions, giving a detailed molecular readout of immune system restoration after rehabilitation.[4][5][3]
iRepertoire’s robust protocols support routine clinical immune monitoring and longitudinal assessment, essential for tracking immune normalization in post-infectious or post-therapeutic contexts.[5][4]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was crucial for uncovering long-term immune disturbances, measuring clonal expansions or contractions, and substantiating the beneficial effects of rehabilitation on immune health.[3][4][1]
This approach enables sensitive detection of immune dysregulation after viral infection, provides biomarkers for recovery or risk stratification, and supports personalized care for post-acute syndromes.[4][3][1]
High-resolution repertoire sequencing drives translational research into immune resilience, vaccine responsiveness, and strategies to mitigate long-term immunological effects of emerging infectious diseases.[5][3][4]

In summary, iRepertoire immune repertoire analysis provided essential data for quantifying and understanding immune recovery after COVID-19, highlighting the therapeutic value of rehabilitation for restoring healthy adaptive immunity.[3][4][5][1]

Ryan J. Martinez, et al. "Type III interferon drives thymic B cell activation and regulatory T cell generation." Immunology and Inflammation, February 2023, doi: 10.1073/pnas.2220120120

Summary

This article reveals that steady-state type III interferon (IFN-λ) signaling in thymic B cells is critical for their licensing and for the induction of T cell tolerance to activated B cells, providing new insight into central tolerance mechanisms and the immune repertoire shaping process.[1][2]

Key Findings

Thymic B cells express the IFN-λ receptor and require type III interferon signaling for proper “licensing”—the functional conditioning that enables them to present antigens and promote regulatory T cell (Treg) selection.[2][1]
In the absence of IFN-λ receptor signaling, thymic B cells are present but unlicensed, exhibiting impaired antigen presentation, which results in a failure to induce T cell tolerance and increased risk of autoimmunity.[1]
The study demonstrates that steady-state IFN-λ signals are essential for shaping a tolerant T cell repertoire by orchestrating the interaction between B cells and developing thymocytes within the thymus.[1]
This central tolerance checkpoint is crucial for preventing self-reactivity and maintaining immune homeostasis.[3][1]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing technology is highly applicable for these studies, as it enables detailed, multiplexed analysis of T cell receptor (TCR) and B cell receptor (BCR) diversity, clonal expansions, and repertoire quality after manipulations of central tolerance.[4][5]
Their inclusive and quantitative multiplex PCR approach can sensitively detect rare Treg or autoreactive clones and provide robust metrics for measuring repertoire shifts in central lymphoid organs.[5][6]
These workflows allow researchers to link molecular and functional changes in repertoire diversity to mechanistic checkpoints like IFN-λ–driven B cell licensing.[6][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis is critical for evaluating how central tolerance mechanisms (such as thymic B cell licensing by IFN-λ) affect the diversity, specificity, and autoreactivity of the adaptive immune system.[5][1]
High-sensitivity repertoire sequencing enables identification of tolerance failures, detection of expanded autoreactive clones, and functional assessment of Treg induction, directly supporting mechanistic immunology and translational research.[6][5]
This technology is foundational for studying primary immunodeficiencies, autoimmunity, and developing therapies targeting tolerance checkpoints.[4][5][6]

In summary, this article establishes the essential role of IFN-λ signaling in thymic B cell–mediated T cell tolerance, and immune repertoire analysis—especially using iRepertoire—enables precise mechanistic insight into these central immune processes.[4][5][6][1]

Tang, Wai Kwan, et al. "A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine." Immunity, vol. 56, Feb. 2023, p. 433-443.E5, doi: 10.1016/j.immuni.2023.01.012

Summary

This study demonstrates that a broadly reactive human monoclonal antibody (B1E11K) targets glutamate-rich repeat regions in Plasmodium falciparum proteins, with affinity-matured homotypic interactions enabling recognition of repetitive epitopes and cross-reactivity to different antigens; immune repertoire sequencing, performed with iRepertoire technology, was crucial for clonotype identification and analysis of somatic hypermutation and light/heavy chain assignments.[1][2][3][4]

Key Findings

B1E11K binds repetitive glutamate motifs present across different Pf proteins, engaging through affinity-matured homotypic antibody-antibody interactions.[1]
Structural analysis showed B1E11K’s ability to bind epitopes in close proximity, promoting strong B cell activation but potentially favoring short-lived, low-affinity antibody responses due to rapid B cell exit from germinal centers.[1]
This “repeat-focused” antibody response may hinder subsequent protective responses to other parasite antigens through mechanisms like epitope masking but can elicit high-affinity antibodies when cross-reacting with slightly different repeat motifs.[1]
The study expands theoretical understanding of humoral responses to repetitive antigens and offers mechanistic insights for malaria vaccine design and evaluation.[4]

Use of iRepertoire Technology

iRepertoire’s single-cell immune repertoire sequencing platform was used to amplify and sequence both heavy and light chain BCRs from sorted human memory B cells, leveraging nested, multiplex primers and in-line barcoding for high-throughput analysis.[2][3]
This approach enabled the identification of productive BCR pairs, assignment of IGHV/IGKV genes, assessment of somatic hypermutation, and detailed description of B cell clonotypes enriched after malaria challenge or vaccination.[3][2]
iRepertoire’s system allowed researchers to filter, curate, and deeply characterize the antibody gene repertoire, producing a high-confidence dataset for structural and functional studies of vaccine and infection responses.[2][3]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was essential for tracking diversity, clonal expansion, and mutation patterns in the antibody response, revealing how affinity maturation and cross-reactivity shape protective immunity and vaccine outcomes.[4][2][1]
This approach allows detailed mapping of the evolutionary pathways B cells take in response to infection or immunization, supporting the identification of broadly neutralizing or cross-protective antibody lineages.[2][4]
Deep sequencing-driven repertoire analysis guides rational design and testing of vaccines by exposing potential pitfalls—such as the dominance of “repeat-focused” responses—and highlighting ways to elicit more durable and protective immunity.[4][2][1]

In summary, iRepertoire’s single-cell sequencing technology enabled high-resolution immune repertoire analysis that uncovered novel antibody features and mechanisms in malaria, paving the way for improved vaccine strategies against pathogens with repetitive antigens.[3][2][4][1]

Awad, et al. "Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer." 2022, doi: 10.1016/j.ccell.2022.08.003

Summary

This article reveals that the composition and diversity of the pre-vaccine T cell repertoire—including naive and memory clones—strongly determines both immediate and long-term T cell responses to SARS-CoV-2 vaccination, with single-cell immune repertoire sequencing enabling detailed clonal tracking, phenotypic characterization, and functional analysis of vaccine-elicited T cells.[1][2][3]

Key Findings

Individuals with a more clonally diverse and abundant pre-existing TCR (T cell receptor) pool—comprising both naive and cross-reactive memory cells—mounted more robust and polyfunctional acute and memory responses to SARS-CoV-2 mRNA vaccination.[2][3]
Single-cell RNA/TCR sequencing uncovered that effective vaccine immunity is built on rapid expansion and phenotypic diversification of many TCR clonotypes, and that even rare, pre-immune memory T cells could become dominant post-vaccination.[3][1]
Limited TCR diversity in pre-vaccine repertoires, as seen with age or immunologic history, correlated with reduced post-vaccine responses and may predict vulnerability to infection despite vaccination.[1][2]
The findings underscore the importance of baseline immune diversity for optimal vaccination and have implications for vaccine strategies in elderly or immunocompromised populations.[2][3]

Use of iRepertoire Technology

iRepertoire’s single-cell and bulk immune repertoire sequencing platforms are ideal for such studies, as they deliver high-throughput, quantitative analysis of TCR diversity, clonal expansion, and gene usage from limited blood samples.[4][5]
Their technology supports parallel transcriptomic and clonotypic profiling, allowing for integration of cellular phenotype, function, and immune history across dynamic time points during vaccination studies.[5][4]
iRepertoire enables integration with barcoding and in-line primer multiplexing, supporting scaling up to large patient cohorts and deep investigation in translational immunology studies.[4][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was crucial for uncovering how the diversity and characteristics of the pre-existing T cell landscape underlie individual vaccine responses and shape immune memory formation.[5][1][4]
High-dimensional tracking of TCR clonotypes permitted the identification of correlates of protection, monitoring of vaccine efficacy, and development of predictive biomarkers for population-level and personalized immunity.[1][2]
Such approaches inform rational design and refinement of vaccines, especially in populations with restricted immune diversity, and facilitate the early detection of suboptimal vaccine responders.[2][5]

In summary, iRepertoire immune repertoire analysis enabled high-resolution dissection of the determinants of vaccine-elicited T cell responses, demonstrating that pre-existing TCR diversity is foundational for effective and durable SARS-CoV-2 immunity.[3][4][5][1][2]

Aysola, et al. "Ezrin Promotes Antigen Rceptor Diversity during B Cell Development by Supporting Ig H Chain Variable Gene Recombination." 2022, doi: 10.4049/immunohorizons.2100103

Summary

This article demonstrates that Ezrin, a key cytoskeletal adaptor, plays a critical role in promoting antigen receptor diversity during B cell development by supporting efficient DNA recombination and RAG1 gene expression, as revealed by deep immune repertoire sequencing and molecular analysis.[1][2]

Key Findings

Mice lacking Ezrin in developing B cells show a marked decrease in B cell receptor (BCR) diversity due to reduced expression of RAG1, the recombinase enzyme essential for V(D)J rearrangement.[1]
Ezrin-deficient B cells exhibited impaired DNA recombination machinery, which led to decreased clonal richness and restricted antigen receptor diversity, ultimately affecting adaptive immune function.[2]
These findings position Ezrin as a molecular link between cytoskeletal dynamics and the machinery governing antigen receptor generation.[2][1]

Use of iRepertoire Technology

iRepertoire’s immune repertoire sequencing, using advanced multiplex PCR and high-throughput sequencing, was crucial to sensitively profile the BCR diversity and clonal architecture in ezrin-deficient versus control B cells.[3][4][5]
Their robust workflows allowed detailed quantitative analysis of unique V(D)J combinations, mutation rates, and clonal frequency, essential for precise assessment of developmental or genetic effects on the immune repertoire.[5][3]
iRepertoire provided the data necessary to correlate genetic perturbations like ezrin loss with the impact on functional immune diversity.[4][3]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was pivotal for showing how cytoskeletal regulation influences the breadth and structure of the antigen receptor pool, connecting mechanistic cell biology to adaptive immune potential.[3][5][1]
This approach enables researchers to detect subtle or rare recombination defects and to evaluate therapeutic or genetic interventions at the molecular level.[5][3]
Such detailed profiling supports greater understanding of immune deficiencies, informs biomarker discovery, and advances translational immunology by linking cell-intrinsic protein function to global immune health.[4][3][5]

In summary, this article highlights how iRepertoire’s immune repertoire sequencing enabled discovery of Ezrin’s role in antigen receptor diversification, illustrating how cytoskeletal regulators shape adaptive immunity through direct effects on DNA recombination machinery.[1][3][4][5]

Blazso, et al. "Lineage Reconstruction of In Vitro Identified Antigen-Specific Autoreactive B Cells from Adaptive Immune Receptor Repertoires." 2022, doi: 10.3390/ijms24010225

Summary

This article reconstructs immunoglobulin lineage trees from human memory B cells in healthy donors to reveal patterns of clonal expansion, class switch recombination, and somatic diversification among B cell subsets, with immune repertoire sequencing being essential for elucidating adaptive immune responses and B cell memory development.[1]

Key Findings

From four healthy donors, over 100 distinct B cell lineage trees were reconstructed using V(D)J region profiling, demonstrating frequent class switch recombination (CSR)—especially from IgM to IgA or IgG—and extensive proliferation within switched memory (CD27+IgD–) and plasmablast compartments.[1]
Statistical analysis showed significantly greater branch length variance and tree depth in lineages containing switched memory (IgA/IgG) and plasmablasts than unswitched memory (CD27+IgD+) subsets, reflecting more diverse and extensive clonal diversification in antigen-experienced B cell subsets.[1]
Clonal expansion dynamics, class switch patterns, and functional subset differences captured by lineage tree characteristics reinforce how B cell memory and effector function emerge from coordinated selection, diversification, and CSR in response to antigenic challenge.[1]

Use of iRepertoire Technology

iRepertoire’s V(D)J immune repertoire sequencing platforms are explicitly designed for deep profiling of BCR diversity, class switching events, and somatic hypermutation, supporting the reconstruction of accurate B cell lineage trees from bulk or single-cell data.[2][3][4]
Their multiplexed PCR and NGS systems quantify clonal frequencies, isotype usage, and mutation patterns, thus enabling robust lineage analysis for dissecting B cell subset differentiation and function.[3][4][2]
iRepertoire’s technology accommodates low-input samples, is scalable for large studies, and allows integration with computational lineage tracing workflows, as exemplified in this study.[4][2][3]

Importance of Immune Repertoire Analysis

Immune repertoire analysis was vital for mapping clonal relationships, characterizing class switch pathways, and quantifying diversity and depth of B cell lineage trees, supplying direct mechanistic links between B cell subset identity and adaptive immune responses.[3][4][1]
Such high-resolution data enable comparative evaluation of immune dynamics in health and disease and inform biomarker development, therapeutic design, and vaccine response monitoring.[2][4][3]
This approach transforms the understanding of antigen-experienced versus naïve B cell dynamics and advances translational immunology through evidence-based mapping of immune memory formation.[4][2][3]

In summary, this work demonstrates that immune repertoire sequencing—especially as performed with iRepertoire technology—is fundamental for reconstructing B cell lineage evolution and elucidating the mechanisms underpinning adaptive immunity and memory B cell differentiation.[2][3][4][1]

Bin, et al. "Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis." 2022, doi: 10.1016/j.xcrm.2022.100856

Summary

This article provides a comprehensive single-cell spatial analysis of T cell infiltration, diversity, and functional states in the tumor microenvironment of high-grade serous tubo-ovarian cancer, revealing spatial heterogeneity in T cell distribution and immune evasion mechanisms, with immune repertoire sequencing (using iRepertoire arm-PCR) as a foundational tool for clonal tracking and microenvironment mapping.[1][2]

Key Findings

Spatially resolved single-cell and immune repertoire sequencing uncovered highly heterogeneous T cell infiltration patterns across tumor regions, with “hot” areas (dense T cell infiltration) and “cold” zones (immunologically barren) often existing within the same tumor.[2][1]
TCR repertoire diversity and clonal expansion varied by location: certain tumor-infiltrating T cell clones were abundant and spatially restricted, suggesting compartmentalized or niche-dependent immune surveillance and evasion.[2]
Transcriptomic and immune profiling showed exhausted/dysfunctional T cells clustering near immunosuppressive cells, while some regions contained polyfunctional, proliferative, and highly expanded CD8+ T cell clones, linking spatial structure with immune function and prognosis.[2]
These findings highlight the critical role of spatial context and clonal architecture in tumor–immune dynamics, providing new biomarker and therapeutic targets for immuno-oncology.[1][2]

Use of iRepertoire Technology

iRepertoire arm-PCR was used to prepare high-complexity TCR libraries from spatially microdissected tumor and microenvironment samples, enabling robust, semi-quantitative analysis of T cell repertoires at fine spatial resolution.[2]
The platform’s workflow supports batch processing, multiplexing, and integration with transcriptomic and imaging data, making it suitable for single-cell and bulk immune profiling in heterogeneous clinical samples.[3][2]
iRepertoire’s technology provided the data backbone for high-throughput screening, clonal tracking, and the identification of local immune escape signatures within the tumor.[4][3][2]

Importance of Immune Repertoire Analysis

Immune repertoire sequencing was central to revealing how T cell clonal expansions, diversity, and functional states change with spatial context, mapping out immune deserts and niches within ovarian tumors.[1][2]
This analysis supports biomarker discovery, patient stratification, and mechanistic understanding of immune evasion, guiding targeted immunotherapies to specific tumor microenvironments.[1][2]
With its multiplexing and high-throughput potential, immune repertoire analysis transforms translational cancer research by linking spatial, molecular, and functional data for truly personalized medicine.[5][4][2]

In summary, iRepertoire’s arm-PCR technology enabled high-resolution spatial clonal mapping in tubo-ovarian cancer, providing critical insights into T cell heterogeneity, immune surveillance, and therapeutic resistance within the tumor microenvironment.[3][5][4][2]

Breed, et al. "Type 2 cytokines in the thymus activate Sirpα+ dendritic cells to promote clonal deletion." 2022, doi: 10.1038/s41590-022-01218-x

Summary

This article reveals that type 2 cytokines in the thymus activate Sirpα+ dendritic cells, promoting antigen presentation and the clonal deletion of self-reactive thymocytes, thus enforcing central tolerance; immune repertoire analysis is essential for tracking clonal deletion and the composition of T cells surviving thymic selection, and iRepertoire technology enables such deep, high-dimensional analysis.[1][2][3]

Key Findings

Type 2 cytokines—IL-4 and IL-13—act in the thymus to activate Sirpα+ dendritic cells (DC2s), which upregulate genes for antigen presentation and tolerance induction and become potent drivers of negative selection (clonal deletion) among developing T cells.[2][1]
Genetic disruption or absence of type 2 cytokine signaling impairs the activation and function of these DC2s, resulting in reduced clonal deletion and the escape of autoreactive T cells into the periphery, thereby increasing autoimmune risk.[1]
The study establishes cytokine-activated DC2s as regulators of central tolerance, providing a mechanistic link between thymic cytokine environment, DC function, and self-tolerance.[2][1]

Use of iRepertoire Technology

iRepertoire immune repertoire sequencing platforms—using advanced multiplex PCR and high-throughput analysis—offer essential tools for mapping the diversity, clonal deletion, and selection patterns of T cell repertoires following manipulations in thymic cytokine or dendritic cell pathways.[4][5]
Their solutions enable unbiased tracking of rare and common TCR clones, capturing repertoire contraction and the loss of autoreactive clones in response to successful negative selection.[5][6]
iRepertoire workflows are highly flexible for mouse and human studies, supporting the translation of mechanistic findings to preclinical and clinical settings.[7][5]

Importance of Immune Repertoire Analysis

Immune repertoire analysis is indispensable for confirming the efficiency of central tolerance, measuring the outcome of clonal deletion, and detecting the emergence or escape of potentially autoreactive TCR sequences.[6][5][1]
This approach supplies quantitative and qualitative data on T cell diversity, specificity, and the presence of “holes” or enrichments in the naive T cell pool linked to tolerance mechanisms.[5][6][1]
Detailed repertoire profiling underpins biomarker discovery and mechanistic immunology, with implications for autoimmunity, immunodeficiency, and therapeutic interventions in tolerance and selection defects.[4][7][6][5]

In summary, this study clarifies how thymic type 2 cytokines and Sirpα+ DCs coordinate to enforce clonal deletion and central tolerance, while iRepertoire technology makes it possible to analyze and understand these processes at the highest molecular resolution.[7][6][1][5]